RANGWALA RESHMA (EVP & Chief Medical Officer) sold 0.7% of their position (408.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $3.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2026ACC: 0001193125-26-226685
Officer· EVP & Chief Medical Officer
Since Apr 2022
+539.00
Net shares
Net buyer
$3.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
947.00 acquired · 408.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+947.00
Price / share
—
Trade value
—
% of position
1.7%
5/13/2026
56.29K→57.24K
Common Stock
Direct
Shares
−408.00
Price / share
$9.50
Trade value
$3.88K
% of position
0.7%
5/14/2026
57.24K→56.83K
Total
Net shares
+539.00
Net value
-$3.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | A · Award | +947.00 | — | — | 1.7% | 56.29K | 57.24K |
| Common Stock Direct | 5/14/2026 | S · Sale | −408.00 | $9.50 | $3.88K | 0.7% | 57.24K | 56.83K |
| Total | +539.00 | -$3.88K | ||||||
Derivative Transactions0
No derivative transactions reported